Top 5 Growth Opportunities for the Pharmaceutical Industry in 2024
23 févr. 2024 04h38 HE
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024" report has been added to ResearchAndMarkets.com's offering. In 2024, the life...
Combination Therapy in Aesthetics Market Size to Exceed US$ 8.03 Billion by 2034 with 8.1 % CAGR: Fact.MR Analysis
13 févr. 2024 08h00 HE
|
FACT.MR
Rockville, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Fact.MR, a market research and competitive intelligence provider, states that the global combination therapy in aesthetics market is estimated at a value...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma
15 nov. 2023 09h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose...
Mercury Poisoning Treatment Market to Exceed USD 50 million by 2030, Says Transparency Market Research
28 sept. 2023 11h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The mercury poisoning treatment market was valued at US$ 32 million in 2019. The mercury...
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to reach USD 30.4 billion by 2031, expanding at a CAGR of 4.4%: TMR Report
09 août 2023 05h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market is projected to flourish at a CAGR of 4.4% from 2022...
Global Anti-Hypertensive Drugs Market Analysis and Outlook 2023-2027: FDA Emphasizes Rise of Combination Therapies for Hypertension Treatment
28 juil. 2023 05h38 HE
|
Research and Markets
Dublin, July 28, 2023 (GLOBE NEWSWIRE) -- The "Anti-Hypertensive Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global anti-hypertensive drugs...
Antihypertensive Drugs Market Projected to Expand at a CAGR of 3.0% from 2022 to 2030, Data by Contrive Datum Insights
16 janv. 2023 08h58 HE
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The Antihypertensive Drugs Market is estimated to reach a valuation of USD 30.2 Billion by 2022, growing at 3.0% CAGR during the assessment period...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
30 nov. 2022 05h48 HE
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Global Bacteriophage Therapy Market Report 2022: Minimal Drug Toxicity, Self-Replication and Less Side Effects Among Benefits Fueling Adoption
28 nov. 2022 08h43 HE
|
Research and Markets
Dublin, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The "Bacteriophage Therapy Market: Distribution by Therapeutic Area, Route of Administration, and Geography: Industry Trends and Global Forecasts,...
Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the Alpha DaRT Treatment and Standard-of-Care Immunotherapy, Chemotherapy and Anti-Angiogenic Therapy
08 sept. 2022 16h05 HE
|
Alpha Tau Medical Ltd.
– Study on combination with anti-PD1 therapy published by International Journal of Radiation Oncology, Biology, Physics, known in the field as the Red Journal, the official journal of the American...